On Jun 29, 2018 Xenetic Biosciences Inc (NASDAQ:XBIO) Sellers Strengthened Their Shorts By 500%

June 29, 2018 - By Carey Conley

Xenetic Biosciences, Inc. (NASDAQ:XBIO) Corporate Logo

It was registered an increase on Xenetic Biosciences Inc (NASDAQ:XBIO)’s shares shorted with 500%. FINRA announced in June XBIO’s total 600 shares shorted. The 100 previous shares are up with 500%. With Average volume 8,500, XBIO’s former position will take 0 days to restore. Xenetic Biosciences Inc’s shares shorted float is 0.03%.

XBIO reached $3.9601 during the last trading session after $0.6999 change.Xenetic Biosciences, Inc. has volume of 210,799 shares. Since June 29, 2017 XBIO has declined 48.99% and is downtrending. The stock underperformed the S&P 500 by 61.56%.

Xenetic Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, research, and development of biologic drugs and orphan oncology therapeutics.The firm is worth $34.52 million. The Company’s lead proprietary technology is PolyXen, a platform technology for biologic drug delivery.Currently it has negative earnings. The companyÂ’s lead drug candidate is XBIO-101, a small-molecule immunomodulator and interferon inducer for the treatment of progesterone receptor negative endometrial cancer and triple negative breast cancer.

For more Xenetic Biosciences, Inc. (NASDAQ:XBIO) news published briefly go to: Benzinga.com, Benzinga.com, Benzinga.com, Benzinga.com or Benzinga.com. The titles are as follows: “24 Stocks Moving In Friday’s Pre-Market Session” published on June 29, 2018, “40 Stocks Moving In Tuesday’s Mid-Day Session” on June 26, 2018, “42 Biggest Movers From Yesterday” with a publish date: June 28, 2018, “36 Stocks Moving In Monday’s Mid-Day Session” and the last “26 Stocks Moving In Tuesday’s Pre-Market Session” with publication date: June 26, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.